Morningside Venture Investments Ltd Kezar Life Sciences, Inc. (KZR) insider trading activity

Morningside Venture Investments LTD is of Kezar Life Sciences, Inc.. Currently has a direct ownership of 1.95 Million shares of KZR, which is worth approximately $12.9 Million. The most recent transaction as insider was on Aug 15, 2023, when has been sold 3,500,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.95M

0% 3M change

0% 12M change

Total Value Held $12.9 Million

Morningside Venture Investments Ltd Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 15 2023	SELL Bona fide gift	-	3,500,000 Reduced 64.24%	1,947,993 Common Stock
Feb 06 2023	SELL Open market or private sale	$275,200 $6.88 p/Share	40,000 Reduced 0.73%	5,447,993 Common Stock
Feb 03 2023	SELL Open market or private sale	$178,750 $7.15 p/Share	25,000 Reduced 0.45%	5,487,993 Common Stock
Feb 02 2023	SELL Open market or private sale	$359,500 $7.19 p/Share	50,000 Reduced 0.9%	5,512,993 Common Stock
Feb 01 2023	SELL Open market or private sale	$278,000 $6.95 p/Share	40,000 Reduced 0.71%	5,562,993 Common Stock
Jan 31 2023	SELL Open market or private sale	$212,400 $7.08 p/Share	30,000 Reduced 0.53%	5,602,993 Common Stock
Jan 30 2023	SELL Open market or private sale	$207,300 $6.91 p/Share	30,000 Reduced 0.53%	5,632,993 Common Stock
Jan 25 2023	SELL Open market or private sale	$342,500 $6.85 p/Share	50,000 Reduced 0.88%	5,662,993 Common Stock
Jan 24 2023	SELL Open market or private sale	$558,400 $6.98 p/Share	80,000 Reduced 1.38%	5,712,993 Common Stock
Jan 23 2023	SELL Open market or private sale	$544,800 $6.81 p/Share	80,000 Reduced 1.36%	5,792,993 Common Stock
Jan 17 2023	SELL Open market or private sale	$41,514 $6.79 p/Share	6,114 Reduced 0.1%	5,872,993 Common Stock
Jan 13 2023	SELL Open market or private sale	$14,092 $7.15 p/Share	1,971 Reduced 0.03%	5,879,107 Common Stock
Jan 12 2023	SELL Open market or private sale	$33,850 $6.77 p/Share	5,000 Reduced 0.08%	5,881,078 Common Stock
Jan 06 2023	SELL Open market or private sale	$20,670 $6.89 p/Share	3,000 Reduced 0.05%	5,886,078 Common Stock
Jan 05 2023	SELL Open market or private sale	$84,769 $6.97 p/Share	12,162 Reduced 0.21%	5,889,078 Common Stock
Jan 04 2023	SELL Open market or private sale	$215,100 $7.17 p/Share	30,000 Reduced 0.51%	5,901,240 Common Stock
Jan 03 2023	SELL Open market or private sale	$3,550 $7.1 p/Share	500 Reduced 0.01%	5,931,240 Common Stock
Dec 29 2022	SELL Open market or private sale	$177,500 $7.1 p/Share	25,000 Reduced 0.42%	5,931,740 Common Stock
Oct 04 2022	SELL Open market or private sale	$31,858 $8.82 p/Share	3,612 Reduced 0.06%	6,076,740 Common Stock
Oct 03 2022	SELL Open market or private sale	$251,986 $8.78 p/Share	28,700 Reduced 0.47%	6,080,352 Common Stock

Also insider at

APLS

Apellis Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

AMLX

Amylyx Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

GRNA

GreenLight Biosciences Holdings, PBC Healthcare

MVI